Newborn Jaundice Treatment
The Right Wavelength, a Safe Future. Advanced Technology Solutions for Neonatal Jaundice
Phototherapy is a critical intervention for newborns that protects not only their skin color but also their neurological development, cellular health, and future quality of life. NOVOS Jaundice Treatment Solutions, with a broad portfolio ranging from high-intensity LED phototherapy devices for use on top of incubators to mini phototherapy modules that can be integrated into radiant heaters and tunnel-type high-intensity phototherapy devices, precisely reduces infants’ bilirubin levels to safe levels.
The advanced phototherapy technologies we have designed for newborns shorten the treatment duration by ensuring continuous and safe bilirubin breakdown at the optimal wavelength, and provide the key to creating the ideal microenvironment for the healthy development of the most vulnerable lives.
What Is Hyperbilirubinemia (Newborn Jaundice)?
Neonatal jaundice is a condition characterized by elevated bilirubin levels in the blood and the accumulation of this substance in tissues, causing the skin and sclera (the white part of the eye) to turn yellow. Because newborns’ liver enzymes are not yet fully mature and bilirubin metabolism is not functioning at full capacity, they require external support (phototherapy). For this reason, bilirubin management is not merely a matter of visual monitoring; it is a process that must be actively and carefully managed to prevent neurotoxic risks.
Why Are Newborns Prone to Jaundice?
Newborns encounter physiological barriers to bilirubin clearance during the postnatal adaptation process:
Physiological Barriers: In newborns, red blood cells (erythrocytes) have a shorter lifespan and a larger volume; this increases the bilirubin load released following their breakdown.
Insufficient Conjugation: The enzymatic mechanisms in the liver responsible for binding bilirubin and converting it into a form that can be excreted from the body (UGT1A1 activity) have not yet fully developed.
It is important to remember that neonatal jaundice is not merely a temporary “change in skin color.” Free bilirubin molecules are capable of crossing the blood-brain barrier. If high bilirubin levels are not treated promptly and appropriately, they can lead to irreversible neurological damage (Acute Bilirubin Encephalopathy and Kernicterus), directly threatening motor skills, hearing function, and cognitive development.
The Gold Standard in Jaundice Management. Effective Irradiance
The primary goal of phototherapy is not merely to expose the infant to blue light, but to treat the infant within the Effective Spectral Irradiance limits specified by clinical guidelines.
What Is Effective Phototherapy?
For bilirubin to initiate the process of photoisomerization (conversion to a water-soluble form that can be easily excreted from the body), light from a source must reach the infant’s skin at a specific wavelength (ideally 460–490 nm) and with sufficient intensity (irradiance). When this specific balance is achieved:
Indirect bilirubin is converted into photoisomers without requiring conjugation by the liver and is rapidly eliminated from the body via urine and feces.
By keeping the duration of treatment at an optimal level, mother-infant separation is minimized and hospital stays are shortened.
Treatment failures caused by insufficient radiation and the associated risks of invasive procedures (blood exchange) are eliminated.
In conclusion, ensuring effective phototherapy through the use of the correct wavelength and an optimized device design plays a critical role in protecting the neurological health of newborns and increasing clinical success rates.
Safe Treatment, Perfect Microclimatic Adaptation
Discover the NOVOS Phototherapy Devices—designed to target the most effective wavelength (460–490 nm) as recommended by clinical guidelines and developed to provide maximum protection for the baby’s neurological health—and explore our innovative solutions
Bilisphere 360 LED: 360° Power, Maximum Speed, and Complete Confidence in Bilirubin Management.
Every detail is critical in the treatment of hyperbilirubinemia. Bilisphere 360 LED is not just a phototherapy device; it is a comprehensive solution that simultaneously optimizes the newborn’s safety, treatment speed, and clinical outcomes.
Bililed Maxi+ Phototherapy System
We offer an advanced phototherapy system featuring a long LED lifespan and an expanded effective surface area. NOVOS Bililed Maxi+ high-intensity phototherapy delivers excellent treatment results for newborns with hyperbilirubinemia.
